...
首页> 外文期刊>BMC Microbiology >Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair
【24h】

Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair

机译:评估从动脉粥样硬化组织中纯化DNA的五种DNA提取方法的评估,以及评估接受血管修复的丹麦人群中肺炎衣原体的患病率

获取原文
   

获取外文期刊封面封底 >>

       

摘要

To date PCR detection of Chlamydia pneumoniae DNA in atherosclerotic lesions from Danish patients has been unsuccessful. To establish whether non-detection was caused by a suboptimal DNA extraction method, we tested five different DNA extraction methods for purification of DNA from atherosclerotic tissue. The five different DNA extraction methods were tested on homogenate of atherosclerotic tissue spiked with C. pneumoniae DNA or EB, on pure C. pneumoniae DNA samples and on whole C. pneumoniae EB. Recovery of DNA was measured with a C. pneumoniae-specific quantitative real-time PCR. A DNA extraction method based on DNA-binding to spin columns with a silica-gel membrane (DNeasy Tissue kit) showed the highest recovery rate for the tissue samples and pure DNA samples. However, an automated extraction method based on magnetic glass particles (MagNA Pure) performed best on intact EB and atherosclerotic tissue spiked with EB. The DNeasy Tissue kit and MagNA Pure methods and the highly sensitive real-time PCR were subsequently used on 78 atherosclerotic tissue samples from Danish patients undergoing vascular repair. None of the samples were positive for C. pneumoniae DNA. The atherosclerotic samples were tested for inhibition by spiking with two different, known amounts of C. pneumoniae DNA and no samples showed inhibition. As a highly sensitive PCR method and an optimised DNA extraction method were used, non-detection in atherosclerotic tissue from the Danish population was probably not caused by use of inappropriate methods. However, more samples may need to be analysed per patient to be completely certain on this. Possible methodological and epidemiological reasons for non-detection of C. pneumoniae DNA in atherosclerotic tissue from the Danish population are discussed. Further testing of DNA extraction methods is needed as this study has shown considerable intra- and inter-method variation in DNA recovery.
机译:迄今为止,来自丹麦患者的动脉粥样硬化病变中的肺炎衣原体DNA的PCR检测尚未成功。为了确定未检测到是否由次优的DNA提取方法引起,我们测试了五种不同的DNA提取方法以从动脉粥样硬化组织中纯化DNA。在掺有肺炎衣原体DNA或EB的动脉粥样硬化组织的匀浆,纯肺炎衣原体DNA样品和整个肺炎衣原体EB上测试了五种不同的DNA提取方法。用肺炎衣原体特异性定量实时PCR测量DNA的回收率。一种基于DNA结合到硅胶膜上的离心柱的DNA提取方法(DNeasy Tissue kit)显示了组织样品和纯DNA样品的最​​高回收率。但是,基于磁性玻璃颗粒(MagNA Pure)的自动提取方法在完整的EB和掺有EB的动脉粥样硬化组织中效果最好。 DNeasy Tissue试剂盒和MagNA Pure方法以及高灵敏度的实时PCR随后用于来自丹麦接受血管修复的患者的78个动脉粥样硬化组织样品。所有样品均无肺炎衣原体DNA阳性。通过用两种不同的已知量的肺炎衣原体DNA加标来测试动脉粥样硬化样品的抑制作用,并且没有样品显示出抑制作用。由于使用了高度灵敏的PCR方法和优化的DNA提取方法,因此,使用适当的方法可能不会导致丹麦人群的动脉粥样硬化组织未检出。但是,可能需要为每位患者分析更多样本,以完全确定这一点。讨论了在丹麦人群的动脉粥样硬化组织中未检出肺炎衣原体DNA的可能的方法学和流行病学原因。需要进行DNA提取方法的进一步测试,因为该研究表明DNA回收中方法内和方法间存在很大差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号